The Levers And Tradeoffs That Drive Process Productivity

Increasing titers isn’t the only way to maximize process efficiency. Whether you’re optimizing an existing process or developing the next generation of biologics, we can help you identify the levers that matter most.

Join us for an interactive discussion on the process decisions, tradeoffs, and operational realities shaping modern biologics manufacturing. Bioprocess Online’s Tyler Menichiello will moderate a conversation with two industry experts bringing firsthand experience in process development and biopharmaceutical manufacturing:

• David Scherr, Ph.D., Senior Scientist, Bioprocessing Technologies and Engineering at AstraZeneca
• Vadim Klyushnichenko, Ph.D., VP, Biopharmaceutical Development and Quality at Calibr-Skaggs Institute for Innovative Medicines

Scherr and Klyushnichenko will discuss where productivity gains are actually achieved and how teams are finding success by simplifying purification strategies and reducing chromatography steps. They will also explore how less obvious constraints (e.g., developability and facility fit) can shape productivity early and how complex molecules like bispecifics are redefining what process efficiency looks like.

Reserve your spot today.